Clinical Trials Directory

Trials / Unknown

UnknownNCT06169358

Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy

Status
Unknown
Phase
Study type
Observational
Enrollment
627 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to understand the epidemiological status of Fabry in patients with hypertrophic cardiomyopathy or left ventricular hypertrophy through multi-center early identification of high-risk patients in cardiology according to high-risk profiles, supplemented by DBS (dried blood disc) screening tools, and to explore the screening and diagnosis methods of patients with Fabry disease in cardiology, so as to promote the early identification, diagnosis and treatment of Fabry in cardiology.

Conditions

Timeline

Start date
2023-10-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2023-12-13
Last updated
2023-12-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06169358. Inclusion in this directory is not an endorsement.